/ pharma stocks
/ Market Analysis
Pfizer Shares Gain Amid Reports of Deal with the US Government
Pfizer stock climbed over 3% on news of an impending drug-pricing deal with the Trump administration.
September 30, 2025
Why Did Rapport Therapeutics, Inc Shares Skyrocket in Premarket?
Rapport Therapeutics shares surged in premarket trading after announcing positive Phase 2a trial results for RAP-219, showing 77.8% reduction in clinical seizures.
September 08, 2025
Novo Nordisk: Is the Ozempic Hype Train Finally Slowing Down?
Ozempic-famed Novo Nordisk took over a $70 billion wipeout off its market value this week. Is this the beginning of a trend, or a great opportunity?
July 31, 2025
Why did Novo Nordisk’s Stock Crash Over 20% in Premarket Trading Today?
Novo Nordisk stock crashed over 20% in premarket trading after the company cut its 2025 forecast for the second time.
July 29, 2025
Why is CELC Skyrocketing in Premarket Trading Today?
Celcuity's stock surged over 112% in premarket trading following positive Phase 3 trial results for its breast cancer treatment, marking a potential breakthrough in targeted cancer therapy.
July 28, 2025More from The Tokenist / pharma stocks
Why did XAGE Stock Surge in Today’s Premarket Trading?
July 15, 2025
Back to 
